Man Group PLC Voyager Therapeutics, Inc. Transaction History

Man Group PLC

$36 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$7.42 - $10.54 $432,378 - $614,186	-58,272 Reduced 79.58%	14,957 $118,000
Q1 2024 May 15, 2024	BUY	$7.15 - $10.84 $407,993 - $618,552	57,062 Added 352.95%	73,229 $681,000
Q4 2023 Feb 14, 2024	SELL	$6.28 - $8.81 $27,010 - $37,891	-4,301 Reduced 21.01%	16,167 $136,000
Q3 2023 Nov 14, 2023	BUY	$7.55 - $11.25 $154,533 - $230,265	20,468 New	20,468 $158,000
Q1 2023 May 15, 2023	BUY	$6.0 - $10.78 $57,762 - $103,779	9,627 Added 45.68%	30,704 $236,000
Q4 2022 Feb 14, 2023	BUY	$4.94 - $6.61 $104,120 - $139,318	21,077 New	21,077 $128,000
Q2 2022 Aug 15, 2022	SELL	$4.82 - $10.09 $99,301 - $207,874	-20,602 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.75 - $9.44 $56,655 - $194,482	20,602 New	20,602 $157,000
Q2 2021 Aug 16, 2021	SELL	$3.94 - $5.44 $67,768 - $93,568	-17,200 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$4.61 - $9.04 $489,397 - $959,686	-106,160 Reduced 86.06%	17,200 $81,000
Q4 2020 Feb 16, 2021	BUY	$7.15 - $12.28 $3,575 - $6,140	500 Added 0.41%	123,360 $882,000
Q3 2020 Nov 16, 2020	SELL	$10.01 - $13.75 $21,021 - $28,875	-2,100 Reduced 1.68%	122,860 $1.31 Million
Q2 2020 Aug 14, 2020	SELL	$8.05 - $14.21 $96,422 - $170,207	-11,978 Reduced 8.75%	124,960 $1.58 Million
Q1 2020 May 15, 2020	BUY	$6.8 - $14.66 $129,030 - $278,173	18,975 Added 16.09%	136,938 $1.25 Million
Q4 2019 Feb 18, 2020	BUY	$12.82 - $16.85 $655,909 - $862,096	51,163 Added 76.59%	117,963 $1.65 Million
Q3 2019 Nov 14, 2019	BUY	$16.31 - $28.29 $1.09 Million - $1.89 Million	66,800 New	66,800 $1.15 Million
Q1 2019 May 15, 2019	SELL	$8.0 - $19.66 $89,128 - $219,032	-11,141 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$8.59 - $18.05 $15,401 - $32,363	-1,793 Reduced 13.86%	11,141 $105,000
Q3 2018 Nov 14, 2018	BUY	$17.11 - $21.74 $221,300 - $281,185	12,934 New	12,934 $245,000

Others Institutions Holding VYGR

# of Institutions

130

Shares Held

34.7M

Call Options Held

39.7K

Put Options Held

34.6K

Black Rock Inc. New York, NY

5.31M
Shares

$30.7 Million
0.0% of portfolio
Armistice Capital, LLC New York, NY

5.2M
Shares

$30.1 Million
0.5% of portfolio
Eco R1 Capital, LLC San Francisco, CA

3.92M
Shares

$22.6 Million
0.99% of portfolio
Vanguard Group Inc Valley Forge, PA

3.19M
Shares

$18.4 Million
0.0% of portfolio
Farallon Capital Management LLC San Francisco, CA

2.29M
Shares

$13.2 Million
0.07% of portfolio

View Full List

About Voyager Therapeutics, Inc.

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $223M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

More about VYGR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Account